Get the Stockscreener App
28.41
0.31%
0.089
After Hours:
28.14
-0.27
-0.95%
Tema Oncology Etf stock is traded at $28.41, with a volume of 2,261.
It is up +0.31% in the last 24 hours and down -4.89% over the past month.
See More
Previous Close:
$28.32
Open:
$28.39
24h Volume:
2,261
Relative Volume:
0.38
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-0.21%
1M Performance:
-4.89%
6M Performance:
+1.04%
1Y Performance:
+0.00%
1-Day Range:
$28.09
$28.42
1-Week Range:
$28.03
$28.63
52-Week Range:
$21.26
$30.11
Tema Oncology Etf Stock (CANC) Company Profile
Name
Tema Oncology Etf
Sector
Industry
Phone
-
Address
-
Tema Oncology Etf Stock (CANC) Latest News
Thrivent Financial for Lutherans Invests $8.62 Million in Tema Oncology ETF (NASDAQ:CANC) - Defense World
(CANC) Technical Data - Stock Traders Daily
7 Best-Performing Biotech ETFs for September 2024 - NerdWallet
Tema Oncology ETF (NASDAQ:CANC) Short Interest Update - Defense World
Where are the Opportunities in (CANC) - Stock Traders Daily
5 Small-cap Biotech ETFs to Watch (Updated 2024) - Investing News Network
5 Small-cap Biotech ETFs to Watch (Updated 2024) - Nasdaq
Tema Oncology ETF (NASDAQ:CANC) Sees Large Decrease in Short Interest - Defense World
When the Price of (CANC) Talks, People Listen - Stock Traders Daily
Beyond Novo and Eli Lilly: Watch these biotech and weight loss drug names, fund manager says - CNBC
Tema American Reshoring ETF: Benefiting From The Return Of U.S. Manufacturing - Seeking Alpha
EXCLUSIVE: GLP-1 Weight-Loss Drugs Could Become A Trillion-Dollar Market, Predicts Tema ETFs CEO - Quantisnow
5 Small-cap Biotech ETFs to Watch (Updated 2024) | INN - Investing News Network
Tema ETFs CIO on Investment Opportunities in Biotech - Opto RoW
9 Best Biotech ETFs for 2024 - MSN
How Big Pharma Is Taking A Page Out Of Novartis' Playbook - Investor's Business Daily
10 Best Performing Biotech ETFs in 2024 - Yahoo Finance
9 Best Biotech ETFs for 2024 - AOL
Investment Surge in Healthcare ETFs Amidst Weight-Loss Drug Revolution - The PiPa News
11 Best Biotech ETFs To Buy - Insider Monkey
Healthcare ETFs for the Weight-Loss Drug Boom & Beyond - Zacks Investment Research
Healthcare ETFs for the Weight-Loss Drug Boom & Beyond - Yahoo Finance
Is Gilead's 10% Crash — Resulting In A Failed Breakout — An Overreaction? - Investor's Business Daily
EXCLUSIVE: Tema ETFs' Innovative Thematic Investing Approach Targets New Opportunities Beyond The Fads - Markets Insider
Tema ETFs hops on weight-loss drug frenzy with its new cardiovascular fund - Reuters
12 Best Healthcare ETFs To Buy - Yahoo Finance
Investing in Oncology: A Biotech Revolution in Research, Diagnosis, and Treatment of Cancer - Nasdaq
Oncology Market's Huge Potential Puts These Stocks in Focus - Yahoo Finance
Royalties and cancer treatments: Thematic ETFs take new directions - InvestmentNews
How BlackRock’s Rick Rieder is steering his active fixed-income ETF as bond funds struggle - MarketWatch
This Week in ETFs: 2 Funds Launch From Tema - ETFdb.com
Thematic ETFs Struggle to Capture Financial Advisors’ Attention - etf.com
ETFs Start Second Half With Widespread Inflows - Morningstar
Tema launches three innovative, professionally managed thematic ETFs: American Reshoring, Luxury, & Monopolies and Oligopolies - Business Wire
Tema, Backed by Index, Accel and Zinal, Expands Access to Innovative Investment Themes Through Launch of Active ETF Platform - Business Wire
Ukroboronprom to Repair Captured Russian Tanks for Use by Ukrainian Army - Defense World
Pyxis Oncology (PYXS) Stock Price, News & Analysis - MarketBeat
Terns Pharmaceuticals (TERN) Stock Price, News & Analysis - MarketBeat
Cullinan Oncology (CGEM) Stock Price, News & Analysis - MarketBeat
Relay Therapeutics (RLAY) Stock Price, News & Analysis - MarketBeat
Legend Biotech (LEGN) Stock Price, News & Analysis - MarketBeat
Option Care Health (OPCH) Stock Price, News & Analysis - MarketBeat
Schrödinger (SDGR) Stock Price, News & Analysis - MarketBeat
SpringWorks Therapeutics (SWTX) Stock Price, News & Analysis - MarketBeat
Genmab A/S (GMAB) Stock Price, News & Analysis - MarketBeat
Arvinas (ARVN) Stock Price, News & AnalysisNASDAQ - MarketBeat
argenx (ARGX) Stock Price, News & AnalysisNASDAQ - MarketBeat
Cogent Biosciences (COGT) Stock Price, News & Analysis - MarketBeat
Blueprint Medicines (BPMC) Stock Price, News & Analysis - MarketBeat
Exelixis (EXEL) Stock Price, News & AnalysisNASDAQ - MarketBeat
Incyte (INCY) Stock Price, News & AnalysisNASDAQ - MarketBeat
Tema Oncology Etf Stock (CANC) Financials Data
There is no financial data for Tema Oncology Etf (CANC). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.36%
0.35%
Cap:
|
Volume (24h):